37
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report

ORCID Icon, , ORCID Icon, , ORCID Icon &
Pages 1275-1279 | Received 05 Apr 2024, Accepted 26 May 2024, Published online: 30 May 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.